5 February 2013
Coms plc
("Coms", the "Company" or the "Group")
Appointment of Iain Ross as Independent Non-Executive Director
Coms plc (AIM:COMS), the internet telephony service provider, is pleased to announce the appointment of Iain Ross as an Independent Non-Executive Director.
David Breith, CEO commented; "Iain is a Chartered Director and has a wealth of experience having been an NED and Chairman of several listed technology businesses in the UK and overseas. Our ability to attract someone of his experience further validates the new vision, desire and strategy of the Company. We intend to make further Board appointments as appropriate in the near future"
Iain Ross added; "I am looking forward to working with David and his team to build Coms plc into a major player in the sector."
Regulatory Information
Full Name: Iain Gladstone Ross
Age: 59
Current UK Directorships:
Ark Therapeutics Limited
Ark Therapeutics Group plc
Biomer Technology Limited
Gladstone Partners Limited
Pharminox Limited
PowerStax PLC
Tissue Therapies Europe ltd
Yellowcross Limited
Overseas Directorships
Tissue Therapies Ltd (ASX)
Benitec Biopharma Lid (ASX)
Tacere Therapeutics Inc
Directorships held in the last 5 years
Breast Cancer Haven (company limited by guarantee)
Eden BioDesign Limited
Silence Therapeutics plc
Stanford Rook Limited
Trading Haven Limited
There are no other matters which are required to be announced as required under paragraph (g) of Schedule 2 of the AIM Rules.
Contact:
Coms plc
David Breith +44 (0) 20 7148 3148
Northland plc (Nominated Adviser and Joint Broker)
Luke Cairns /William Vandyk +44 (0) 20 7796 8800
XCAP Securities Limited (Broker)
John Belliss +44 (0) 20 7101 7070
Newgate Threadneedle (PR)
Graham Herring/Robyn McConnachie +44 (0) 20 7653 9858